References
- MusaSARobertshawHThomsonSJCowanMLRahmanTMClostridium difficile-associated disease acquired in the neurocritical care unitNeurocrit Care2010131879220443154
- AgbahtKDiazEMuñozEBacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs nonbacteremic ventilator-associated pneumoniaCrit Care Med20073592064207017581489
- L’HériteauFAlbertiCCohenYTrochéGMoinePTimsitJFNosocomial infection and multidrug-resistant bacteria surveillance in intensive care units: a survey in FranceInfect Control Hosp Epidemiol2005261132015693404
- DelmasJChacornacJPRobinFGiammarinaroPTalonRBonnetREvaluation of the Vitek 2 system with a variety of Staphylococcus speciesJ Clin Microbiol200846131131317959759
- NakasoneIKinjoTYamaneNKisanukiKShiohiraCMLaboratory-based evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility testingDiagn Microbiol Infect Dis200758219119817300904
- ShiMYXieHFWeiJPInvestigation of pathogenic bacteria for pulmonary infections and their drug resistance in neurological intensive care unitDi Yi Jun Yi Da Xue Xue Bao200424121441144315604082
- MesarosNNordmannPPlésiatPPseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millenniumClin Microbiol Infect200713656057817266725
- Fernández-CuencaFMartínez-MartínezLConejoMCAyalaJAPereaEJPascualARelationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumanniiJ Antimicrob Chemother200351356557412615856
- KarageorgopoulosDEFalagasMECurrent control and treatment of multidrug-resistant Acinetobacter baumannii infectionsLancet Infect Dis200881275176219022191
- LodiseTPJrLomaestroBDrusanoGLPiperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategyClin Infect Dis200744335736317205441
- GladstonePRajendranPBrahmadathanKNIncidence of carbapenem resistant nonfermenting gram negative bacilli from patients with respiratory infections in the intensive care unitsIndian J Med Microbiol200523318919116100428
- ObritschMDFishDNMacLarenRJungRNosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment optionsPharmacotherapy200525101353136416185180
- VitkauskienėASkrodenienėEDambrauskienėAMacasASakalauskasRPseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortalityMedicina (Kaunas)201046749049520966623
- ZavasckiAPCarvalhaesCGPicãoRCGalesACMultidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapyExpert Rev Anti Infect Ther201081719320014903
- DeresinskiSVancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infectionsClin Infect Dis20094971072107919725789
- FalagasMEBliziotisIAFragoulisKNOral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trialsAm J Infect Control200735210611417327190
- GulloAInvasive fungal infections: the challenge continuesDrugs200969Suppl 1657319877737
- VazquezJAInvasive fungal infections in the intensive care unitSemin Respir Crit Care Med2010311798620101550